AIM: To prepare monoclonal antibodies ( mAbs) against human plasmin α 2 antiplasmin complexes ( PAP). 目的:制备纤溶酶α2抗纤溶酶复合物(PAP)的单克隆抗体(mAb)。
Results Plasma tissue plasminogen activator activity and D dimer ( D D) were significantly elevated at diagnosis, while the plasminogen ( PLG), α 2 antiplasmin(α 2 PI) and plasminogen activator inhibitor ( PAI) activity decreased. 结果患者血浆组织纤溶酶原激活物活性、D-二聚体(D-D)水平显著升高;纤溶酶原活性(PLG)、α2抗纤溶酶活性(α2-PI)、纤溶酶原激活抑制物活性(PAI)水平降低;
CONCLUSION: The mAbs against PAP neoantigens with high affinity was acquired successfully, which provided a tool for determination of plasma levels of PAP without interferences from plasminogen and α 2 antiplasmin and for research on fibrinolytic status in vitro. 结论:成功地制备针对PAP新抗原的具有高亲和力的mAb,为建立不受其前体分子干扰的PAP特异性检测方法,研究纤溶系统的激活状态提供了工具。
Kinetics Study on Antiplasmin Activity of Recombinant TFPI-2 in Vitro 重组TFPI-2抑制纤溶酶活性的酶促动力学实验方法研究